Filing Details
- Accession Number:
- 0001209191-15-041797
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-12 17:12:55
- Reporting Period:
- 2015-05-11
- Filing Date:
- 2015-05-12
- Accepted Time:
- 2015-05-12 17:12:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1130591 | Xenoport Inc | XNPT | Pharmaceutical Preparations (2834) | 943330837 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1235945 | Wendall Wierenga | C/O Xenoport, Inc. 3410 Central Expressway Santa Clara CA 95051 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-05-11 | 5,000 | $5.63 | 28,998 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Denotes average purchase price with a range of $5.61 to $5.64 per share.